![](https://www.microbiometimes.com/wp-content/uploads/2023/06/shutterstock_547320169-326x245.jpg)
Finance
Seres Therapeutics and Nestlé Health Science Announce U.S. Commercial Availability Of Vowst™
Seres Therapeutics, Inc. (Nasdaq: MCRB) and Nestlé Health Science today announced that VOWST™ (fecal microbiota spores, live-brpk) is now commercially available for patients. VOWST, formerly called SER-109, is the first and only U.S. Food and Drug […]